Today's Top 20 Gastroenterology and Endoscopy Stories
-
Takeda partners with UK pharmaceutical company for rare disease development — 3 insights
Takeda partnered with Evox Therapeutics in a deal worth $882 million to develop up to five rare disease programs, Pharmaphorum reports. - 3/27/20 -
Motus GI scores CE Mark approval for colonoscopy prep device — 3 things to know
Motus GI gained CE Mark approval for its GEN2 Pure-Vu System, a colonoscopy device designed to facilitate the cleaning of a poorly prepared colon, according to a March 27 announcement. - 3/27/20 -
4 COVID-19 updates for gastroenterologists this week
Four COVID-19 updates for gastroenterologists this week: - 3/26/20 -
4 resources for GIs treating COVID-19 patients
Gastroenterologists treating COVID-19 patients have a number of resources to help guide them, including statements from professional societies and dedicated websites with information on the virus. - 3/26/20 -
CMS joins call to halt elective gastroenterology procedures during pandemic
CMS recommends that all elective gastroenterology procedures be delayed during the COVID-19 pandemic to free up resources and limit exposure. - 3/25/20 -
How GIs are preparing for COVID-19 & more: 4 GI industry key notes
Here are four updates from gastroenterology companies and practices from the past week: - 3/25/20 -
Any polyp presence raises CRC risk
Patients with polyps had a higher risk of developing colorectal cancer than the general population, according to a study published in Lancet Gastroenterology & Hepatology. - 3/25/20 -
GI societies issue statement on COVID-19, 5 other must-reads this week
Five must read articles for gastroenterologists this week: - 3/24/20 -
AGA releases COVID-19 research collection
The American Gastroenterological Association released a collection of the latest studies around COVID-19 to provide up-to-date research to gastroenterologists. - 3/24/20 -
How gastroenterology practices are responding to COVID-19
Gastroenterologists are adapting their practices to combat the growing COVID-19 pandemic. Here's how they're doing it: - 3/23/20 -
Exact Sciences lowers quarterly, full-year outlook due to COVID-19
Exact Sciences withdrew its first-quarter and full-year financial projections because of the effect of the COVID-19 pandemic, the company announced. - 3/23/20 -
3 COVID-19 updates for gastroenterologists
Three COVID-19 updates for gastroenterologists from this past week: - 3/20/20 -
4 gastroenterology-focused ASCs, facilities recently opened, announced
Here are four gastronenterolog-focused ASCs recently opened or announced: - 3/20/20 -
Baseline colonoscopy results predict 10-year outcomes
Baseline colonoscopy results are highly predictive of 10-year outcomes and can be used to identify patients who could develop advanced neoplasia, Clinical Advisor reports. - 3/20/20 -
CRH Medical's board chairman resigns — 3 insights
CRH Medical lost its board chairman after Dr. Anthony Holler resigned from the board March 19 to focus on "other business matters." - 3/20/20 -
Almost 12% of duodenoscopes remain contaminated after reprocessing
Duodenoscopes have long been the subject of cross-contamination concerns, and a recent study found that more than 10 percent of scopes remained contaminated after reprocessing, Gastroenterology & Endoscopy News reports. - 3/20/20 -
Gastroenterologist advises against home testing kits alone — 3 insights
A Louisiana gastroenterologist warned that at-home colorectal cancer testing kits may not be enough for diagnosing the disease, local ABC affiliate KTBS reports. - 3/20/20 -
3 gastroenterologists making headlines
Three gastroenterologists featured in the news recently: - 3/19/20 -
Chicago gastroenterology practice seeks go-ahead for nearly $8M center
Chicago-based Lincoln Park Gastroenterology Center is seeking state approval to establish an ambulatory surgical treatment center, according to a Feb. 11 document. - 3/19/20 -
Digestive symptoms of COVID-19: What gastroenterologists should know
A study published in The American Journal of Gastroenterology found digestive symptoms were common in patients infected with the coronavirus. - 3/19/20